Protective immunity and reduced renal colonization induced by vaccines containing recombinant Leptospira interrogans outer membrane proteins and flagellin adjuvant

Clinical and Vaccine Immunology

Volumn 22, Issue 8, 2015, Pages 965-973

  Monaris, D ^a,b   Sbrogio Almeida, M E ^a   Dib, C C ^c   Canhamero, T A ^a   Souza, G O ^b   Vasconcellos, S A ^b   Ferreira, L C S ^b   Abreu, P A E ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO BIOLÓGICO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; LEPTOSPIROSIS VACCINE; OUTER MEMBRANE PROTEIN; RECOMBINANT PROTEIN; ALUMINUM HYDROXIDE; BACTERIAL VACCINE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOLOGICAL ADJUVANT; RECOMBINANT VACCINE; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; CIRCULAR DICHROISM; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HAMSTER; IMMUNE RESPONSE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; WESTERN BLOTTING; ANIMAL; BLOOD; GENETICS; IMMUNOLOGY; KIDNEY; MESOCRICETUS; MICROBIOLOGY; SURVIVAL ANALYSIS;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; FLAGELLIN; IMMUNOGLOBULIN G; KIDNEY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; MALE; MESOCRICETUS; SURVIVAL ANALYSIS; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84939537315     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00285-15     Document Type: Article

References (43)

1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM. 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757-771. http://dx.doi.org/10.1016/S1473-3099(03)00830-2.
2. Adler B, De la Pea-Moctezuma A. 2010. Leptospira and leptospirosis. Vet Microbiol 140:287-296. http://dx.doi.org/10.1016/j.vetmic.2009.03 .012.
3. Vijayachari P, Sugunan AP, Shriram AN. 2008. Leptospirosis: an emerging global public health problem. J Biosci 33:557-569. http://dx.doi.org/10.1007/s12038-008-0074-z.
4. World Health Organization. 2011. Leptospirosis: an emerging public health problem. Wkly Epidemiol Rec 86:45-50.
5. Guerra MA. 2013. Leptospirosis: public health perspectives. Biologicals 41:295-297. http://dx.doi.org/10.1016/j.biologicals.2013.06.010.
6. Ellis WA. 1994. Leptospirosis as a cause of reproductive failure. Vet Clin North Am Food Anim Pract 10:463-478.
7. Grooms DL. 2006. Reproductive losses caused by bovine viral diarrhea virus and leptospirosis. Theriogenology 66:624-628. http://dx.doi.org/10.1016/j.theriogenology.2006.04.016.
8. Faine SB, Adler B, Bolin C, Perolat P. 1999. Leptospira and leptospirosis. MediSci, Melbourne, Australia.
9. Dellagostin AO, Grassmann AA, Hartwig DD, Félix SR, Dilva EF, McBride AJA. 2011. Recombinant vaccines against leptospirosis. Hum Vaccin 7:1215-1224. http://dx.doi.org/10.4161/hv.7.11.17944.
10. Ko AI, Goarant C, Picardeau M. 2009. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 7:736-747. http://dx.doi.org/10.1038/nrmicro2208.
11. Haake DA, Mazel MK, McCoy AM, Milward F, Chao G, Matsunaga J, Wagar EA. 1999. Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection. Infect Immun 67:6572-6582.
12. Branger C, Sonrier C, Chatrenet B, Klonjkowski B, Ruvoen-Clouet N, Aubert A, André-Fontaine G, Eliot M. 2001. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect Immun 69:6831-6838. http://dx.doi.org/10.1128/IAI.69.11.6831-6838.2001.
13. Branger C, Chatrenet B, Gauvrit A, Aviat F, Aubert A, Bach JM, André-Fontaine G. 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysinassociated protein 1. Infect Immun 73:4062-4069. http://dx.doi.org/10.1128/IAI.73.7.4062-4069.2005.
14. Seixas FK, da Silva EF, Hartwig DD, Cerqueira GM, Amaral M, Fagundes MQ, Sossa RG, Dellagostin OA. 2007. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88-95. http://dx.doi.org/10.1016/j.vaccine.2007.10.052.
15. Koizumi N, Watanabe H. 2004. Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545-1552. http://dx.doi.org/10.1016/j.vaccine.2003.10.007.
16. Palaniappan RU, McDonough SP, Divers TJ, Chen CS, Pan MJ, Matsumoto M, Chang YF. 2006. Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745-1750. http://dx.doi.org/10.1128/IAI.74.3.1745-1750.2006.
17. Silva EF, Medeiros MA, McBride AJ, Matsunaga J, Esteves GS, Ramos JG, Santos CS, Croda J, Homma A, Dellagostin OA, Haake DA, Reis MG, Ko AI. 2007. The terminal portion of leptospiral immunoglobulinlike protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277-6286. http://dx.doi.org/10.1016/j.vaccine.2007.05.053.
18. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis MS, Aleixo JA, Haake DA. 2011. A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis 5:e1422. http://dx.doi.org/10.1371/journal.pntd.0001422.
19. Forster KM, Hartwig DD, Seixas FK, Bacelo KL, Amaral M, Hartleben CP, Dellagostin OA. 2013. A conserved region of leptospiral immunoglobulin-like A and B proteins as a DNA vaccine elicits a prophylactic immune response against leptospirosis. Clin Vaccine Immunol 20:725-731. http://dx.doi.org/10.1128/CVI.00601-12.
20. Yan W, Faisal SM, McDonough SP, Chang CF, Pan MJ, Akey B, Chang YF. 2010. Identification and characterization of OmpA-like proteins as novel vaccine candidates for leptospirosis. Vaccine 28:2277-2283. http://dx.doi.org/10.1016/j.vaccine.2009.12.071.
21. Matsunaga J, Barocchi MA, Croda J, Young TA, Sanchez Y, Siqueira I, Bolin CA, Reis MG, Riley LW, Haake DA, Ko AI. 2003. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49:929-945. http://dx.doi.org/10.1046/j.1365-2958.2003.03619.x.
22. Palaniappan RU, Chang YF, Jusuf SS, Artiushin S, Timoney JF, Mc-Donough SP, Barr SC, Divers TJ, Simpson KW, McDonough PL, Mohammed HO. 2002. Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun 70: 5924-5930. http://dx.doi.org/10.1128/IAI.70.11.5924-5930.2002.
23. Cerqueira GM, McBride AJ, Picardeau M, Ribeiro SG, Moreira AN, Morel V, Reis MG, Ko AI, Dellagostin OA. 2009. Distribution of the leptospiral immunoglobulin-like (lig) genes in pathogenic Leptospira species and application of ligB to typing leptospiral isolates. J Med Microbiol 58(Pt 9):1173-1181. http://dx.doi.org/10.1099/jmm.0.009175-0.
24. Murray GL, Lo M, Bulach DM, Srikram A, Seemann T, Quinsey NS, Sermswan RW, Allen A, Adler B. 2013. Evaluation of 238 antigens of Leptospira borgpetersenii serovar Hardjo for protection against kidney colonisation. Vaccine 31:495-499. http://dx.doi.org/10.1016/j.vaccine.2012.11.028.
25. Newton SM, Jacob CO, Stocker BA. 1989. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 244:70-72. http://dx.doi.org/10.1126/science.2468182.
26. Newton SM, Kotb M, Poirier TP, Stocker BA, Beachey EH. 1991. Expression and immunogenicity of a streptococcalMprotein epitope inserted in Salmonella flagellin. Infect Immun 59:2158-2165.
27. Sbrogio-Almeida ME, Mosca T, Massis LM, Abrahamsohn IA, Ferreira LC. 2004. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Infect Immun 72:2546-2555. http://dx.doi.org/10.1128/IAI.72.5.2546-2555.2004.
28. Lee SE, Kim SY, Jeong BC, Kim YR, Bae SJ, Ahn OS, Lee JJ, Song HC, Kim JM, Choy HE, Chung SS, Kweon MN, Rhee JH. 2006. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun 74:694-702. http://dx.doi.org/10.1128/IAI.74.1.694-702.2006.
29. Huleatt JW, Nakaar V, Desai P, Huang Y, Hewitt D, Jacobs A, Tang J, McDonald W, Song L, Evans RK, Umlauf S, Tussey L, Powell TJ. 2008. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 26:201-214. http://dx.doi.org/10.1016/j.vaccine.2007.10.062.
30. Braga CJ, Massis LM, Alencar BC, Rodrigues MM, Sbrogio-Almeida ME, Ferreira LC. 2008. Cytotoxic T cell adjuvant effects of three Salmonella enterica flagellins. Braz J Microbiol 39:44-49. http://dx.doi.org/10.1590/S1517-83822008000100011.
31. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol 21:335-376. http://dx.doi.org/10.1146/annurev.immunol.21.120601.141126.
32. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680. http://dx.doi.org/10.1038/90609.
33. Akira S, Takeda K. 2004. Toll-like receptor signalling. Nat Rev Immunol 4:499-511. http://dx.doi.org/10.1038/nri1391.
34. Barbosa AS, Abreu PA, Neves FO, Atzingen MV, Watanabe MM, Vieira ML, Morais ZM, Vasconcellos SA, Nascimento AL. 2006. A newly identified leptospiral adhesin mediates attachment to laminin. Infect Immun 74:6356-6364. http://dx.doi.org/10.1128/IAI.00460-06.
35. Setubal JC, Reis M, Matsunaga J, Haake DA. 2006. Lipoprotein computational prediction in spirochaetal genomes. Microbiology 152(Pt 1): 113-121. http://dx.doi.org/10.1099/mic.0.28317-0.
36. Barbosa AS, Monaris D, Silva LB, Morais ZM, Vasconcellos SA, Cianciarullo AM, Isaac L, Abreu PA. 2010. Functional characterization of LcpA, a surface-exposed protein of Leptospira spp. that binds the human complement regulator C4BP. Infect Immun 78:3207-3216. http://dx.doi.org/10.1128/IAI.00279-10.
37. Castiblanco-Valencia MM, Fraga TR, Silva LB, Monaris D, Abreu PA, Strobel S, Józsi M, Isaac L, Barbosa AS. 2012. Leptospiral immunoglobulin-like proteins interact with human complement regulators factor H, FHL-1, FHR-1, and C4BP. J Infect Dis 205:995-1004. http://dx.doi.org/10.1093/infdis/jir875.
38. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
39. Souza NM, Vieira ML, Alves IJ, de Morais ZM, Vasconcellos SA, Nascimento AL. 2012. Lsa30, a novel adhesin of Leptospira interrogans binds human plasminogen and the complement regulator C4bp. Microb Pathog 53:125-134. http://dx.doi.org/10.1016/j.micpath.2012.06.001.
40. Gómez RM, Vieira ML, Schattner M, Malaver E, Watanabe MM, Barbosa AS, Abreu PA, de Morais ZM, Cifuente JO, Atzingen MV, Oliveira TR, Vasconcellos SA, Nascimento AL. 2008. Putative outer membrane proteins of Leptospira interrogans stimulate human umbilical vein endothelial cells (HUVECS) and express during infection. Microb Pathog 45:315-322. http://dx.doi.org/10.1016/j.micpath.2008.08 .004.
41. Mendes RS, Von Atzingen M, de Morais ZM, Gonçales AP, Serrano SM, Asega AF, Romero EC, Vasconcellos SA, Nascimento AL. 2011. The novel leptospiral surface adhesin Lsa20 binds laminin and human plasminogen and is probably expressed during infection. Infect Immun 79: 4657-4667. http://dx.doi.org/10.1128/IAI.05583-11.
42. Lucas DS, Cullen PA, Lo M, Srikram A, Sermswan R, Adler B. 2011. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29:3413-3418. http://dx.doi.org/10.1016/j.vaccine.2011.02.084.
43. Chang YF, Chen CS, Palaniappan RU, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF. 2007. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25:8190-8197. http://dx.doi.org/10.1016/j.vaccine.2007.09.020.